Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003115 · ClinicalTrials.gov registry record · NA
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
A NA study of End Stage Renal Disease on Dialysis, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05003115 is a NA study of End Stage Renal Disease on Dialysis that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 30 participants, below the 74-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05003115, a NA study of End Stage Renal Disease on Dialysis, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study addresses the need to rigorously advance the science and understanding of the development, feasibility, acceptability and adoption of novel culturally-sensitive motivational strategies to improve dialysis treatment adherence among African Americans with end-stage kidney disease (ESKD). This study specifically aims to: 1. Gain advanced skills in the development and implementation of novel culturally sensitive motivational strategies 2. Acquire critical preliminary data for an R01-funded phase II efficacy trial testing the use of these motivational strategies to improve dialysis treatment adherence.
Conditions Studied
Interventions
- BEHAVIORAL Motivational interviewing
Study Locations (2)
Tennessee
- Vanderbilt Dialysis Clinic - Nashville
- Vanderbilt Dialysis Clinic East - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2023-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05003115
The ClinicalTrials.gov registry entry for NCT05003115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (59% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 1 intervention - of which Motivational interviewing is the first listed.
NCT05003115 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05003115 about?
NCT05003115 is a clinical study titled "Motivational Strategies To Empower African Americans To Improve Dialysis Adherence". This study addresses the need to rigorously advance the science and understanding of the development, feasibility, acceptability and adoption of novel culturally-sensitive motivational strategies to improve dialysis treatment adherence among African Americans with end-stage kidney disease (ESKD). Th...
What is the current status of trial NCT05003115?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-06-06. Estimated completion is 2023-01-09.
What conditions does trial NCT05003115 study?
This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.
What interventions are being tested in trial NCT05003115?
The interventions under investigation include: Motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05003115?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05003115 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease on Dialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
RECRUITING · NA
-
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
RECRUITING · NA
-
The Home Blood Pressure (BP) Trial
ACTIVE NOT RECRUITING · NA
-
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
ACTIVE NOT RECRUITING · NA
-
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
COMPLETED · NA
-
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.